2 Univ. of Tokyo researchers implicated in fabrication in 5 papers

2 Univ. of Tokyo researchers implicated in fabrication in 5 papers

TOKYO, Japan, Aug. 1 Kyodo - File photo taken in February 2016 shows Yoshinori Watanabe, professor in the University of Tokyo's Institute of Molecular and Cellular Biosciences. The university said on Aug. 1, 2017, that Watanabe and Yuji Tanno, who was a research associate in Watanabe's laboratory, were involved in six fabrications and 10 alterations in five papers on cell division.

Indonesia approves emergency use of China's mRNA COVID-19 vaccine

STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog